Evidence map›Paper›PMID 41560306›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Decoding Human Placental Cellular and Molecular Responses to Obesity and Fetal Growth.

Hong Jiang, Emilie Derisoud, Denise Parreira, Nayere Taebnia, Paulo R Jannig, Reza Zandi Shafagh, Allan Zhao, Congru Li, Macarena Ortiz, Manuel Alejandro Maliqueo and 3 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hong JiangKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Emilie DerisoudKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Denise ParreiraKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Nayere TaebniaKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Paulo R JannigKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Reza Zandi ShafaghKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Allan ZhaoKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Congru LiKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Macarena OrtizUniversity of Chile, Departamento De Medicina Interna, Santiago, Chile.
Manuel Alejandro MaliqueoUniversity of Chile, Departamento De Medicina Interna, Santiago, Chile.
Elisabet Stener-VictorinKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Volker M LauschkeKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.
Qiaolin DengKarolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-5934-7816

Funding

BarndiabetesfondenDiabetes foundation DIA2022-733Diabetes Foundation DIA2021-633Distinguished Investigator Grant-Endocrinology and MetabolismInnovative Medicines Initiative 2 Joint Undertaking 875510Karolinska Institutet Faculty funded positionKarolinska Institutet-China scholarship council programKnut and Alice Wallenberg Foundation 2019.0211Knut and Alice Wallenberg Foundation VC-2021-0026Knut och Alice Wallenbergs Stiftelse 2019.0211Knut och Alice Wallenbergs Stiftelse VC-2021-0026Robert Bosch StiftungScientific and Technological Development 1181798Swedish Medical Research Council 2018-02557Swedish Medical Research Council 2020-00253Swedish Medical Research Council 2021-02801Swedish Medical Research Council 2022-00550Swedish Medical Research Council 2022-06725Swedish Medical Research Council 2023-03015Swedish Medical Research Council 2024-03401
6 · The paper itself

Abstract

Maternal obesity increases the risks of large-for-gestational-age (LGA) births and subsequent cardiometabolic disorders in offspring. To identify placental signatures associated with these outcomes, we performed single-nucleus RNA sequencing on placentas from women with obesity delivering appropriate-for-gestational-age or LGA infants, compared to normal-weight controls. In maternal obesity, regardless of fetal growth, syncytiotrophoblasts showed upregulated hypoxia and TNF-α signaling, while cytotrophoblasts exhibited downregulated receptor tyrosine kinase signaling. However, villous non-trophoblasts displayed upregulated TNF-α signaling and inflammatory responses only in LGA placentas. Notably, Hofbauer cells in LGA placentas presented transcriptional alterations in immunometabolism-related genes and displayed elevated SPP1 expression, which potentially acts as a ligand for other placental cell types. We modeled key aspects of syncytiotrophoblast responses to adipose tissue using a customized microfluidic organoids-on-a-chip co-culture system. These findings revealed gene expression patterns of placental cells to maternal obesity that are shared or different between O-A and O-L, highlighting pathways for future mechanistic investigation.

Indexed as

Fetal DevelopmentObesityPlacentaPregnancy in ObesityAdultDevelopmental Origins of Health and DiseaseFemaleHumansInfant, Large for Gestational AgePregnancyTrophoblastsbirth weightmaternal obesitymicrofluidic co‐cultureplacental transcriptomicssingle‐nucleus RNA sequencing

Identifiers

PMID41560306
PMCPMC13042494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.